Inicio › Leucemia mielógena aguda › Georgia › Atlanta
Ensayos clínicos de Leucemia mielógena aguda en Atlanta, GA
31 estudios para Leucemia mielógena aguda buscan participantes en centros de Atlanta y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
ReclutandoFase 1
- Children'S Healthcare Of Atlanta - Arthur M. Blank Hospital /ID# 275740, Atlanta
Ivosidenib as Post-HSCT Maintenance for AML
ReclutandoFase 2
- Emory University Hospital, Atlanta
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
ReclutandoFase 1
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
ReclutandoFase 2/3
- Winship Cancer Institute of Emory University /ID# 279006, Atlanta
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Atlanta VA Medical Center, Decatur · A 6 mi de distancia
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
ReclutandoEstudio observacional
- Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
ReclutandoFase 1
- Emory University Hospital/Winship Cancer Institute, Atlanta
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
ReclutandoFase 1
- Emory University, Atlanta
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
ReclutandoFase 3
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
ReclutandoFase 1/2
- Emory Winship Cancer Institute, Atlanta
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
ReclutandoFase 2
- Winship Cancer Institute - Emory University, Atlanta
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
ReclutandoFase 3
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
ReclutandoFase 3
- US-Atlanta GA-EMORY, Atlanta
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
ReclutandoFase 3
- US-Atlanta GA-EMORY, Atlanta
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
ReclutandoFase 1/2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
ReclutandoFase 3
- Children's Healthcare of Atlanta, Atlanta
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
ReclutandoFase 1
- Emory Healthcare - The Emory Clinic, Atlanta
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
ReclutandoFase 1
- Children's Healthcare of Atlanta, Atlanta
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
ReclutandoFase 1Se aceptan voluntarios sanos
- Northside Hospital, Atlanta
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
ReclutandoFase 3
- Emory University - Winship Cancer Institute (WCI), Atlanta
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
ReclutandoEstudio observacional
- Children's Healthcare of Atlanta, Atlanta
- Northside Hospital, Atlanta
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
ReclutandoFase 1/2
- Emory Winship Cancer Institute, Atlanta
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
ReclutandoFase 1
- Winship Cancer Institute / Emory University, Atlanta
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
ReclutandoFase 2/3
- University of Emory - Winship Cancer Institute, Atlanta
Pilot Imaging Study of Leukemia
ReclutandoFase 1
- Emory University, Atlanta
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
ReclutandoFase 1
- Emory Healthcare - The Emory Clinic, Atlanta
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
ReclutandoFase 2Se aceptan voluntarios sanos
- Northside Hospital, Atlanta
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ReclutandoFase 1
- Emory University Hospital, Atlanta
Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
ReclutandoFase 1
- Emory University - WINSHIP Cancer Center, Atlanta
- Emory University, Children's Healthcare of Atlanta, Atlanta
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
ReclutandoFase 1
- Blood and Marrow Transplant Group of Georgia, Atlanta
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
ReclutandoSe aceptan voluntarios sanos
- Emory University, Atlanta
Más información sobre Leucemia mielógena aguda en MedlinePlus
Ensayos de Leucemia mielógena aguda en otras ciudades
- Houston, TX85 estudios
- New York City, NY51 estudios
- Boston, MA44 estudios
- Seattle, WA41 estudios
- Baldwin Park, CA40 estudios
- Columbus, OH35 estudios
- Philadelphia, PA34 estudios
- Durham, NC33 estudios
- Tampa, FL29 estudios
- Chicago, IL26 estudios
- Portland, OR25 estudios
- Washington, DC24 estudios
Otros estudios en Atlanta
- Cáncer (todos los tipos)49 estudios
- Cáncer de pulmón de células no pequeñas47 estudios
- Mieloma múltiple42 estudios
- Cáncer de seno41 estudios
- Cáncer de próstata33 estudios
- Cáncer de ovario29 estudios
- Cáncer del colon y del recto29 estudios
- Cáncer de pulmón29 estudios
- Cáncer metastásico28 estudios
- Trastorno depresivo mayor25 estudios
- Fallo cardíaco25 estudios
- Carcinoma de células escamosas de cabeza y cuello24 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.